Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled Trial

Author:

Grossmann Mathis12ORCID,Robledo Kristy P3,Daniel Mark4,Handelsman David J5ORCID,Inder Warrick J6,Stuckey Bronwyn G A7,Yeap Bu B8ORCID,Ng Tang Fui Mark12,Bracken Karen3,Allan Carolyn A9,Jesudason David1011,Zajac Jeffrey D12,Wittert Gary A12ORCID

Affiliation:

1. Department of Medicine, Austin Health, The University of Melbourne , Heidelberg, VIC 3084 , Australia

2. Department of Endocrinology, Austin Health , Heidelberg, VIC 3084 , Australia

3. NHMRC Clinical Trials Centre, University of Sydney , Camperdown, NSW 2050 , Australia

4. Department of Population Health, Dasman Diabetes Institute , Kuwaiit City , Kuwait

5. Department of Andrology, ANZAC Research Institute, University of Sydney and Department of Andrology, Concord Hospital , Concord, NSW 2139 , Australia

6. Department of Endocrinology, Princess Alexandra Hospital and the University of Queensland , Woolloongabba, QLD 4102 , Australia

7. Keogh Institute for Medical Research, Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital and Medical School, University of Western Australia , Western Australia, Woolloongabba, QLD 4102 , Australia

8. Medical School, University of Western Australia and Department of Endocrinology and Diabetes, Fiona Stanley Hospital , Nedlands, WA 6009 , Australia

9. School of Clinical Sciences at Monash Health and Faculty of Medicine, Nursing and Health Sciences, Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Monash University, Clayton, VIC 3168, Australia

10. Department of Medicine, University of Adelaide , Adelaide, SA 5005 , Australia

11. Department of Endocrinology, The Queen Elizabeth Hospital , Woodville South, SA 5011 , Australia

12. Freemasons Foundation Centre for Men's Health, University of Adelaide , Adelaide, SA 5001 , Australia

Abstract

Abstract Objective To determine the effect of testosterone vs placebo treatment on health-related quality of life (HR-QOL) and psychosocial function in men without pathologic hypogonadism in the context of a lifestyle intervention. Design, Setting, Participants Secondary analysis of a 2-year randomized controlled testosterone therapy trial for prevention or reversal of newly diagnosed type 2 diabetes, enrolling men ≥ 50 years at high risk for type 2 diabetes from 6 Australian centers. Interventions Injectable testosterone undecanoate or matching placebo on the background of a community-based lifestyle program. Main Outcomes Self-reported measures of HR-QOL/psychosocial function. Results Of 1007 participants randomized into the Testosterone for Type 2 Diabetes Mellitus (T4DM) trial, 648 (64%) had complete data available for all HR-QOL/psychosocial function assessments at baseline and 2 years. Over 24 months, while most measures were not different between treatment arms, testosterone treatment, compared with placebo, improved subjective social status and sense of coherence. Baseline HR-QOL/psychosocial function measures did not predict the effect of testosterone treatment on glycemic outcomes, primary endpoints of T4DM. Irrespective of treatment allocation, larger decreases in body weight were associated with improved mental quality of life, mastery, and subjective social status. Men with better baseline physical function, greater sense of coherence, and fewer depressive symptoms experienced greater associated decreases in body weight, with similar effects on waist circumference. Conclusion In this diabetes prevention trial, weight loss induced by a lifestyle intervention improved HR-QOL and psychosocial function in more domains than testosterone treatment. The magnitude of weight and waist circumference reduction were predicted by baseline physical function, depressive symptomology, and sense of coherence.

Funder

National Health and Medical Research Council

Publisher

The Endocrine Society

Reference22 articles.

1. Effects of testosterone replacement in hypogonadal men;Snyder;J Clin Endocrinol Metab,2000

2. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men;Wang;J Clin Endocrinol Metab,2000

3. Effects of testosterone treatment in older men;Snyder;N Engl J Med,2016

4. The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials;Ponce;J Clin Endocrinol Metab,2018

5. Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis;Hudson;Lancet Healthy Longev,2023

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3